NeurAxis is a medical technology company focused on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults. NeurAxis is dedicated to advancing its IB-Stim therapy based on its proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology through evidence-based research to drive adoption by the clinical and scientific communities. With FDA clearance for functional abdominal pain associated with IBS in children and ongoing clinical trials for multiple other conditions, NeurAxis is focused on serving the unmet healthcare needs of children and adults. Founded in 2012, with corporate offices in Carmel, IN, and a distribution center in Versailles, IN, NeurAxis is committed to increasing awareness and broad access to its technology for children and adults.

Stock Performance



Data Provided by Refinitiv. Minimum 15 minutes delayed.